Eli Lilly (LLY) stock rises 3% on Foundayo prescription data and heart study

TLDR Eli Lilly’s obesity pill, Foundio, received 1,390 prescriptions in the United States in its first week of launch, ending April 10. Novo Nordisk’s oral Wegovy received 3,071 prescriptions in just the first four days after its launch on January…













